APO Research
Talk to an analyst

APO RESEARCH · REPORT

Natural Origin Excipient

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Natural Origin Excipient Market Outlook and Growth Opportunities 2026

30 December 2025190 pages

Choose your research edition.

Industry ResearchNatural Origin Excipient Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Natural Origin Excipient Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Natural Origin Excipient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Natural Origin Excipient Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Natural Origin Excipient Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Natural Origin Excipient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Natural Origin Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Natural Origin Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Natural Origin Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Natural Origin Excipient market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Natural Origin Excipient market include BASF, Roquette Freres, Croda Health Care, Colorcon and Ashland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Natural Origin Excipient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Natural Origin Excipient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Natural Origin Excipient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Natural Origin Excipient market size, projected growth trends, production technologies, key applications, and end-use industries.

Natural Origin Excipient Segment by Company

BASF

Roquette Freres

Croda Health Care

Colorcon

Ashland

Natural Origin Excipient Segment by Type

Gelatin

Glucose

Lactose

Cellulose

Sucrose

Natural Origin Excipient Segment by Application

Parenteral Formulations

Oral Formulations

Topical Formulations

Other

Natural Origin Excipient Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Natural Origin Excipient status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Natural Origin Excipient market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Natural Origin Excipient significant trends, drivers, influence factors in global and regions.

6. To analyze Natural Origin Excipient competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Origin Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Natural Origin Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Origin Excipient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Natural Origin Excipient market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Natural Origin Excipient industry.

Chapter 3: Detailed analysis of Natural Origin Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Natural Origin Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Natural Origin Excipient in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Natural Origin Excipient Industry Trends Table 2. Natural Origin Excipient Industry Drivers Table 3. Natural Origin Excipient Industry Opportunities and Challenges Table 4. Natural Origin Excipient Industry Restraints Table 5. Global Natural Origin Excipient Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Natural Origin Excipient Revenue Share by Company (2021-2026) Table 7. Global Natural Origin Excipient Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Natural Origin Excipient Sales Volume Share by Company (2021-2026) Table 9. Global Natural Origin Excipient Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Natural Origin Excipient Company Ranking, (2024-2026) & (USD Million) Table 11. Global Natural Origin Excipient Key Company Manufacturing Base & Headquarters Table 12. Global Natural Origin Excipient Company, Product Type & Application Table 13. Global Natural Origin Excipient Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Natural Origin Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gelatin Table 18. Significant Companies of Glucose Table 19. Significant Companies of Lactose Table 20. Significant Companies of Cellulose Table 21. Significant Companies of Sucrose Table 22. Global Natural Origin Excipient Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Natural Origin Excipient Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Natural Origin Excipient Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Natural Origin Excipient Sales Volume Share by Type (2021-2026) Table 26. Global Natural Origin Excipient Sales Volume Share by Type (2027-2032) Table 27. Global Natural Origin Excipient Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Natural Origin Excipient Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Natural Origin Excipient Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Natural Origin Excipient Sales Value Share by Type (2021-2026) Table 31. Global Natural Origin Excipient Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Parenteral Formulations Table 33. Significant Companies of Oral Formulations Table 34. Significant Companies of Topical Formulations Table 35. Significant Companies of Other Table 36. Global Natural Origin Excipient Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Natural Origin Excipient Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Natural Origin Excipient Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Natural Origin Excipient Sales Volume Share by Application (2021-2026) Table 40. Global Natural Origin Excipient Sales Volume Share by Application (2027-2032) Table 41. Global Natural Origin Excipient Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Natural Origin Excipient Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Natural Origin Excipient Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Natural Origin Excipient Sales Value Share by Application (2021-2026) Table 45. Global Natural Origin Excipient Sales Value Share by Application (2027-2032) Table 46. Global Natural Origin Excipient Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Natural Origin Excipient Sales by Region (2021-2026) & (K Units) Table 48. Global Natural Origin Excipient Sales Market Share by Region (2021-2026) Table 49. Global Natural Origin Excipient Sales by Region (2027-2032) & (K Units) Table 50. Global Natural Origin Excipient Sales Market Share by Region (2027-2032) Table 51. Global Natural Origin Excipient Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Natural Origin Excipient Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Natural Origin Excipient Sales Value Share by Region (2021-2026) Table 54. Global Natural Origin Excipient Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Natural Origin Excipient Sales Value Share by Region (2027-2032) Table 56. Global Natural Origin Excipient Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Natural Origin Excipient Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Natural Origin Excipient Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Natural Origin Excipient Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Natural Origin Excipient Sales by Country (2021-2026) & (K Units) Table 61. Global Natural Origin Excipient Sales Market Share by Country (2021-2026) Table 62. Global Natural Origin Excipient Sales by Country (2027-2032) & (K Units) Table 63. Global Natural Origin Excipient Sales Market Share by Country (2027-2032) Table 64. Global Natural Origin Excipient Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Natural Origin Excipient Sales Value Market Share by Country (2021-2026) Table 66. Global Natural Origin Excipient Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Natural Origin Excipient Sales Value Market Share by Country (2027-2032) Table 68. BASF Company Information Table 69. BASF Business Overview Table 70. BASF Natural Origin Excipient Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. BASF Natural Origin Excipient Product Portfolio Table 72. BASF Recent Development Table 73. Roquette Freres Company Information Table 74. Roquette Freres Business Overview Table 75. Roquette Freres Natural Origin Excipient Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Roquette Freres Natural Origin Excipient Product Portfolio Table 77. Roquette Freres Recent Development Table 78. Croda Health Care Company Information Table 79. Croda Health Care Business Overview Table 80. Croda Health Care Natural Origin Excipient Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Croda Health Care Natural Origin Excipient Product Portfolio Table 82. Croda Health Care Recent Development Table 83. Colorcon Company Information Table 84. Colorcon Business Overview Table 85. Colorcon Natural Origin Excipient Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Colorcon Natural Origin Excipient Product Portfolio Table 87. Colorcon Recent Development Table 88. Ashland Company Information Table 89. Ashland Business Overview Table 90. Ashland Natural Origin Excipient Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ashland Natural Origin Excipient Product Portfolio Table 92. Ashland Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Natural Origin Excipient Distributors List Table 96. Natural Origin Excipient Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Natural Origin Excipient Product Image Figure 2. Global Natural Origin Excipient Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Natural Origin Excipient Sales Value (2021-2032) & (US$ Million) Figure 4. Global Natural Origin Excipient Sales (2021-2032) & (K Units) Figure 5. Global Natural Origin Excipient Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Natural Origin Excipient Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gelatin Image Figure 10. Glucose Image Figure 11. Lactose Image Figure 12. Cellulose Image Figure 13. Sucrose Image Figure 14. Global Natural Origin Excipient Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Natural Origin Excipient Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Natural Origin Excipient Sales Volume Share by Type (2021-2032) Figure 17. Global Natural Origin Excipient Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Natural Origin Excipient Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Natural Origin Excipient Sales Value Share by Type (2021-2032) Figure 20. Parenteral Formulations Image Figure 21. Oral Formulations Image Figure 22. Topical Formulations Image Figure 23. Other Image Figure 24. Global Natural Origin Excipient Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Natural Origin Excipient Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Natural Origin Excipient Sales Volume Share by Application (2021-2032) Figure 27. Global Natural Origin Excipient Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Natural Origin Excipient Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Natural Origin Excipient Sales Value Share by Application (2021-2032) Figure 30. Global Natural Origin Excipient Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Natural Origin Excipient Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Natural Origin Excipient Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Natural Origin Excipient Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Natural Origin Excipient Sales Value (2021-2032) & (US$ Million) Figure 35. North America Natural Origin Excipient Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Natural Origin Excipient Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Natural Origin Excipient Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Natural Origin Excipient Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Natural Origin Excipient Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Natural Origin Excipient Sales Value (2021-2032) & (US$ Million) Figure 41. South America Natural Origin Excipient Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Natural Origin Excipient Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Natural Origin Excipient Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Natural Origin Excipient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Natural Origin Excipient Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Natural Origin Excipient Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Gelatin
  • Glucose
  • Lactose
  • Cellulose
  • Sucrose
Applications
  • Parenteral Formulations
  • Oral Formulations
  • Topical Formulations
  • Other
Companies covered
  • BASF
  • Roquette Freres
  • Croda Health Care
  • Colorcon
  • Ashland

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Natural Origin Excipient Sales Value (2021-2032)
  4. 1.2.2 Global Natural Origin Excipient Sales Volume (2021-2032)
  5. 1.2.3 Global Natural Origin Excipient Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Natural Origin Excipient Market Dynamics
  1. 2.1 Natural Origin Excipient Industry Trends
  2. 2.2 Natural Origin Excipient Industry Drivers
  3. 2.3 Natural Origin Excipient Industry Opportunities and Challenges
  4. 2.4 Natural Origin Excipient Industry Restraints
3 Natural Origin Excipient Market by Company
  1. 3.1 Global Natural Origin Excipient Company Revenue Ranking in 2025
  2. 3.2 Global Natural Origin Excipient Revenue by Company (2021-2026)
  3. 3.3 Global Natural Origin Excipient Sales Volume by Company (2021-2026)
  4. 3.4 Global Natural Origin Excipient Average Price by Company (2021-2026)
  5. 3.5 Global Natural Origin Excipient Company Ranking (2024-2026)
  6. 3.6 Global Natural Origin Excipient Company Manufacturing Base and Headquarters
  7. 3.7 Global Natural Origin Excipient Company Product Type and Application
  8. 3.8 Global Natural Origin Excipient Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Natural Origin Excipient Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Natural Origin Excipient Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Natural Origin Excipient Market by Type
  1. 4.1 Natural Origin Excipient Type Introduction
  2. 4.1.1 Gelatin
  3. 4.1.2 Glucose
  4. 4.1.3 Lactose
  5. 4.1.4 Cellulose
  6. 4.1.5 Sucrose
  7. 4.2 Global Natural Origin Excipient Sales Volume by Type
  8. 4.2.1 Global Natural Origin Excipient Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Natural Origin Excipient Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Natural Origin Excipient Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Natural Origin Excipient Sales Value by Type
  12. 4.3.1 Global Natural Origin Excipient Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Natural Origin Excipient Sales Value by Type (2021-2032)
  14. 4.3.3 Global Natural Origin Excipient Sales Value Share by Type (2021-2032)
5 Natural Origin Excipient Market by Application
  1. 5.1 Natural Origin Excipient Application Introduction
  2. 5.1.1 Parenteral Formulations
  3. 5.1.2 Oral Formulations
  4. 5.1.3 Topical Formulations
  5. 5.1.4 Other
  6. 5.2 Global Natural Origin Excipient Sales Volume by Application
  7. 5.2.1 Global Natural Origin Excipient Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Natural Origin Excipient Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Natural Origin Excipient Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Natural Origin Excipient Sales Value by Application
  11. 5.3.1 Global Natural Origin Excipient Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Natural Origin Excipient Sales Value by Application (2021-2032)
  13. 5.3.3 Global Natural Origin Excipient Sales Value Share by Application (2021-2032)
6 Natural Origin Excipient Regional Sales and Value Analysis
  1. 6.1 Global Natural Origin Excipient Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Natural Origin Excipient Sales by Region (2021-2032)
  3. 6.2.1 Global Natural Origin Excipient Sales by Region: 2021-2026
  4. 6.2.2 Global Natural Origin Excipient Sales by Region (2027-2032)
  5. 6.3 Global Natural Origin Excipient Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Natural Origin Excipient Sales Value by Region (2021-2032)
  7. 6.4.1 Global Natural Origin Excipient Sales Value by Region: 2021-2026
  8. 6.4.2 Global Natural Origin Excipient Sales Value by Region (2027-2032)
  9. 6.5 Global Natural Origin Excipient Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Natural Origin Excipient Sales Value (2021-2032)
  12. 6.6.2 North America Natural Origin Excipient Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Natural Origin Excipient Sales Value (2021-2032)
  15. 6.7.2 Europe Natural Origin Excipient Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Natural Origin Excipient Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Natural Origin Excipient Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Natural Origin Excipient Sales Value (2021-2032)
  21. 6.9.2 South America Natural Origin Excipient Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Natural Origin Excipient Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Natural Origin Excipient Sales Value Share by Country, 2025 VS 2032
7 Natural Origin Excipient Country-level Sales and Value Analysis
  1. 7.1 Global Natural Origin Excipient Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Natural Origin Excipient Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Natural Origin Excipient Sales by Country (2021-2032)
  4. 7.3.1 Global Natural Origin Excipient Sales by Country (2021-2026)
  5. 7.3.2 Global Natural Origin Excipient Sales by Country (2027-2032)
  6. 7.4 Global Natural Origin Excipient Sales Value by Country (2021-2032)
  7. 7.4.1 Global Natural Origin Excipient Sales Value by Country (2021-2026)
  8. 7.4.2 Global Natural Origin Excipient Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Natural Origin Excipient Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Natural Origin Excipient Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Natural Origin Excipient Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Natural Origin Excipient Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF Natural Origin Excipient Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Roquette Freres
  8. 8.2.1 Roquette Freres Company Information
  9. 8.2.2 Roquette Freres Business Overview
  10. 8.2.3 Roquette Freres Natural Origin Excipient Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Roquette Freres Natural Origin Excipient Product Portfolio
  12. 8.2.5 Roquette Freres Recent Developments
  13. 8.3 Croda Health Care
  14. 8.3.1 Croda Health Care Company Information
  15. 8.3.2 Croda Health Care Business Overview
  16. 8.3.3 Croda Health Care Natural Origin Excipient Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Croda Health Care Natural Origin Excipient Product Portfolio
  18. 8.3.5 Croda Health Care Recent Developments
  19. 8.4 Colorcon
  20. 8.4.1 Colorcon Company Information
  21. 8.4.2 Colorcon Business Overview
  22. 8.4.3 Colorcon Natural Origin Excipient Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Colorcon Natural Origin Excipient Product Portfolio
  24. 8.4.5 Colorcon Recent Developments
  25. 8.5 Ashland
  26. 8.5.1 Ashland Company Information
  27. 8.5.2 Ashland Business Overview
  28. 8.5.3 Ashland Natural Origin Excipient Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ashland Natural Origin Excipient Product Portfolio
  30. 8.5.5 Ashland Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Natural Origin Excipient Value Chain Analysis
  2. 9.1.1 Natural Origin Excipient Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Natural Origin Excipient Sales Mode & Process
  6. 9.2 Natural Origin Excipient Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Natural Origin Excipient Distributors
  9. 9.2.3 Natural Origin Excipient Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst